Bracer 1mg tablets
Ferron Par Pharmaceuticals
Ingredients in every tablet
Each package contains
|ATC Level 1||L - Antineoplastic and immunomodulating agents|
|ATC Level 2||L02 - Endocrine Therapy Antineoplastic and Immunomodulating Agents|
|ATC Level 3||L02B - Hormone Antagonists and Related Agents|
18 YEARS OLD AND ABOVE
1 tablet (1 mg) to be taken orally once a day.
Patients with advanced breast cancer:
Anastrozole should be continued until tumor progression is evident.
0 TO 18 YEARS OLD
PATIENTS WITH RENAL IMPAIRMENT
No dose change is recommended in patients with mild or moderate renal impairment.
PATIENTS WITH HEPATIC IMPAIRMENT
No dose change is recommended in patients with mild hepatic disease.
Anastrozole is indicated for the treatment of advanced breast cancer in postmenopausal women with estrogen receptor positive and/or progesterone receptor positive.